早期的COVID-19大流行时期和相关的妊娠期体重增加
Ayomipo Madein1, Lisbet Lundsberg1, Jennifer Culhane1
1Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.
Journal of perinatal medicine
|November 1, 2024
概括
孕期体重增加在早期COVID-19大流行期间保持一致. 这项研究发现,与大流行前时期相比,母亲体重增加没有显著变化,即使考虑到不同的暴露持续时间.
科学领域:
- 孕产妇和胎儿的医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- COVID-19大流行严重影响了日常生活和医疗保健实践.
- 了解它对妊娠结果的影响,如妊娠期体重增加,至关重要.
研究的目的:
- 为了确定早期的COVID-19流行时期是否改变了妊娠期体重增加.
- 为了比较流行病和流行病前队列之间的体重增加模式.
主要方法:
- 在2020年3月至12月期间分娩的5377个人进行了回顾性队列研究.
- 与暂时匹配的流行前对照 (2018-2019) 的比较.
- 使用医学研究所 (IOM) 标准对妊娠期体重增加进行分类;使用多名式逻辑回归.
主要成果:
- 在流行病早期和体重增加低于或高于IOM建议之间没有发现显著的关联.
- 当流行病组在暴露开始时 (<14周和14-20周) 按妊娠年龄分层时,这一发现是正确的.
结论:
- 在COVID-19流行病的早期阶段,没有显著改变母亲的妊娠体重增加.
- 调查结果表明,尽管与大流行相关的变化,怀孕体重管理仍然保持稳定.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


